81 related articles for article (PubMed ID: 32782562)
1. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.
Fuloria S; Yadav G; Menon SV; Ali H; Pant K; Kaur M; Deorari M; Sekar M; Narain K; Kumar S; Fuloria NK
Pathol Res Pract; 2024 May; 259():155346. PubMed ID: 38781762
[TBL] [Abstract][Full Text] [Related]
2. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways [Retraction].
Drug Des Devel Ther; 2024; 18():1263-1264. PubMed ID: 38654923
[TBL] [Abstract][Full Text] [Related]
3. MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2.
Chen X; Wang AL; Liu YY; Zhao CX; Zhou X; Liu HL; Lin MB
Oxid Med Cell Longev; 2020; 2020():5316276. PubMed ID: 33414893
[TBL] [Abstract][Full Text] [Related]
4. miR-429 mediates tumor growth and metastasis in colorectal cancer [Retraction].
Am J Cancer Res; 2020; 10(8):2688. PubMed ID: 32905532
[TBL] [Abstract][Full Text] [Related]
5. miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis.
Gilyazova I; Ivanova E; Gupta H; Mustafin A; Ishemgulov R; Izmailov A; Gilyazova G; Pudova E; Pavlov V; Khusnutdinova E
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002073
[TBL] [Abstract][Full Text] [Related]
6. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies.
Ji Z; Shen J; Lan Y; Yi Q; Liu H
MedComm (2020); 2023 Aug; 4(4):e308. PubMed ID: 37441462
[TBL] [Abstract][Full Text] [Related]
7. HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies.
Bartoszewska S; Sławski J; Collawn JF; Bartoszewski R
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296866
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0084912 Drives the Progression of Cervical Cancer Via Regulating miR-429/SOX2 Pathway.
Du R; Xiong S
Mol Biotechnol; 2023 Dec; 65(12):2018-2029. PubMed ID: 36913084
[TBL] [Abstract][Full Text] [Related]
9. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.
Tang L; Peng L; Tan C; Liu H; Chen P; Wang H
Cancer Cell Int; 2022 Nov; 22(1):349. PubMed ID: 36376832
[TBL] [Abstract][Full Text] [Related]
10. The role of miR-200 family in the regulation of hallmarks of cancer.
Klicka K; Grzywa TM; Mielniczuk A; Klinke A; Włodarski PK
Front Oncol; 2022; 12():965231. PubMed ID: 36158660
[TBL] [Abstract][Full Text] [Related]
11. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
[TBL] [Abstract][Full Text] [Related]
12. CircRNA FUT10 regulates the regenerative potential of aged skeletal muscle stem cells by targeting HOXA9.
Zhu M; Lian C; Chen G; Zou P; Qin BG
Aging (Albany NY); 2021 Jul; 13(13):17428-17441. PubMed ID: 34257163
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma Pathogenesis Leads the Way to New Target Treatments.
Fernandes I; Melo-Alvim C; Lopes-Brás R; Esperança-Martins M; Costa L
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467481
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma.
Yi X; Liu C
Oncol Lett; 2020 Dec; 20(6):370. PubMed ID: 33154768
[TBL] [Abstract][Full Text] [Related]
15. miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway.
Sun L; Wang L; Luan S; Jiang Y; Wang Q
Oncol Lett; 2020 Sep; 20(3):2447-2455. PubMed ID: 32782562
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.
Zhang ZF; Wang YJ; Fan SH; Du SX; Li XD; Wu DM; Lu J; Zheng YL
Oncotarget; 2017 Nov; 8(60):101345-101361. PubMed ID: 29254169
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma.
Zhang ZF; Li GR; Cao CN; Xu Q; Wang GD; Jiang XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8582-8588. PubMed ID: 30575897
[TBL] [Abstract][Full Text] [Related]
18. miR-196 acts as a tumor suppressor in osteosarcoma by targeting HOXA9.
Cao Y; Wu B; Wang D; Bi Z
Int J Clin Exp Pathol; 2018; 11(9):4579-4584. PubMed ID: 31949856
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targets.
Lan M; Zhu XP; Cao ZY; Liu JM; Lin Q; Liu ZL
J Bone Oncol; 2018 Sep; 12():101-104. PubMed ID: 30155405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
